🇺🇸 metformin, gliclazide, protaphane in United States

metformin, gliclazide, protaphane (metformin, gliclazide, protaphane) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

metformin, gliclazide, protaphane in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is metformin, gliclazide, protaphane approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for metformin, gliclazide, protaphane in United States?

Chinese University of Hong Kong is the originator. The local marketing authorisation holder may differ — check the official source linked above.